Jaume Pons
Founder chez ALX ONCOLOGY HOLDINGS INC.
Fortune : 7 M $ au 31/03/2024
Profil
Jaume Pons is the founder of ALX Oncology Ltd.
(founded in 2015) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of ALX Oncology Holdings, Inc. (founded in 2015) where he holds the title of President, Director & Chief Scientific Officer.
Currently, Dr. Pons is the President & Chief Executive Officer of ALX Oncology, Inc. He is also a Director at Tallac Therapeutics, Inc., Alexo Therapeutics International, Sirpant Therapeutics, and a Venture Partner at venBio Partners LLC.
Additionally, he serves as a Scientific Advisor at LSV Capital Management LLC.
In the past, Dr. Pons worked as the Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
He also held the position of Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Dr. Pons completed his graduate degree at the University of California, Berkeley.
He also holds undergraduate, graduate, and doctorate degrees from Universitat Autònoma de Barcelona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/04/2024 | 628 359 ( 1,25% ) | 7 M $ | 31/03/2024 |
Postes actifs de Jaume Pons
| Sociétés | Poste | Début |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Founder | 01/04/2015 |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Founder | 01/04/2015 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The private company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Chief Executive Officer | - |
Alexo Therapeutics International
 Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Director/Board Member | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Director/Board Member | - |
| Sirpant Therapeutics | Director/Board Member | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Consultant / Advisor | - |
Anciens postes connus de Jaume Pons
| Sociétés | Poste | Fin |
|---|---|---|
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/02/2015 |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Formation de Jaume Pons
| University of California, Berkeley | Graduate Degree |
| Universitat Autònoma de Barcelona | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Health Technology |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Finance |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The private company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | Health Technology |
Alexo Therapeutics International
Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
| Sirpant Therapeutics | |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Finance |
